サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：動物用輸液ポンプの世界市場-2022-2029
市場調査レポート
商品コード
1129271

動物用輸液ポンプの世界市場-2022-2029

Global Veterinary Infusion Pumps Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
動物用輸液ポンプの世界市場-2022-2029
出版日: 2022年09月29日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

動物用輸液ポンプは、重病のペットに長期間にわたって栄養溶液を供給するために使用される装置であり、ドーズファッションです。動物用輸液ポンプは、動物のさまざまな臨床的問題に対する体液のモニタリングと分析に不可欠なものとなっています。これは、一定間隔で正確な量の栄養、薬物、および液体を患者の体に制御して供給するものです。これらのポンプのボーラス投与、事前プログラム、スタンバイモード機能は、血液製剤の投与方法を完全に変えることができます。

市場力学

動物用輸液ポンプの技術革新が市場成長の原動力になると予想されます。

特定の生物製剤、遺伝子治療、その他の経口、局所、静脈内投与が不可能な微小分子などの新規薬理物質には、埋め込み型ドラッグデリバリーシステムの進歩が必要です。この侵襲的な投与戦略は、動物の身体がもたらす生理的な障壁を直接乗り越え、治療部位に適切な薬物量を放出し、薬物の効果を確実にするために投与後必要な期間、薬物のバイオアベイラビリティを維持することを目的としています。マイクロテクノロジーの進歩により、特徴的な性能と機能を持つ最新のMEMS対応埋め込み型薬液注入ポンプが実現されています。急性高速放射性標識、がん治療用ナノメディシンの短期投与、慢性眼薬投与は、実験動物研究および前臨床研究におけるマイクロポンプのin vivoデモンストレーションのいくつかの例です。さらに、MEMSアクチュエータやバルブなどの微細構造の研究により、臨床応用に適した小型で優れた性能を持つ次世代の埋め込み型ポンプが実現できる可能性があります。このように、上記の記述から、予測期間において市場の牽引役となることが期待されます。

抑制要因

動物用輸液ポンプのコスト高、デバイスの承認に関する厳しい規制、飼い主の動物の健康に対する意識の欠如、異なる投与セットを使用した輸液ポンプのエラーなどは、予測期間中に市場が阻害されると予想される要因の一部です。

産業分析

動物用輸液ポンプ市場は、サプライチェーン分析、価格分析などの様々な産業要因に基づいて、市場の詳細な分析を提供します。

COVID-19の影響分析

COVID-19の大流行は、ヘルスケアシステムと市場に中程度の影響を及ぼしています。治療または診断目的のために、輸液ポンプは静脈内（IV）または硬膜外方法によって液体を正確に供給する機械です。重力式投与セットと比較して、より高い圧力と高い精度を提供します。輸液ポンプはペットにとって大きなリスクとなるため、輸液や薬剤を投与する際には十分な注意が必要です。輸液速度や輸液量の設定を誤ると、患者に危害が及ぶ可能性があります。どの輸液装置も、ペットの様子を見ながら使用することが大切です。

一方、経済危機は農業と獣医サービスに影響を与え、農場とペットの動物におけるコロナウイルス感染の公衆衛生への影響がより強調されます。さらに、パンデミックはサプライチェーンとプロセスを中断させます。多くの企業は、製品の入手可能性を確保し、サプライチェーンを保護するために、他の地域へと変化していくでしょう。したがって、上記の文から、市場は影響を受け、それは経済活動の再開と迅速に牽引力を得ることが期待されました。

世界の動物用輸液ポンプ市場レポートでは、約45+市場データテーブル、40+図と200ページへのアクセスを提供するであろう。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

  • 市場インパクトファクター
    • 促進要因
      • 動物用輸液ポンプにおける技術革新が市場成長の原動力になる見込み。
    • 抑制要因
      • 動物用輸液ポンプの高コストが市場成長の妨げになると予想されます。
    • 機会
    • 影響分析

第5章 産業分析

  • サプライチェーン分析
  • 価格設定分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 タイプ別

  • 大容量インフュージョンポンプ
  • シリンジ型輸液ポンプ

第8章 移動性別

  • 据置型
  • 携帯型

第9章 チャネルタイプ別

  • シングルチャンネル
  • マルチチャンネル

第10章 注入モード別

  • レートモード
  • 時間モード
  • 投与量モード
  • その他

第11章 エンドユーザー別

  • 動物病院
  • 動物病院
  • ラボラトリー
  • ホームケア
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第13章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第14章 企業プロファイル

  • B. Braun Melsungen AG
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Burtons Medical Equipment Ltd
  • Digicare Biomedical Technology Inc
  • DRE Veterinary
  • Grady Medical System Inc.
  • Heska Corporation
  • Jorgen Kruuse
  • Jorgensen Laboratories
  • Eitan Medical
  • iVet Medical

第15章 動物用輸液ポンプの世界市場-DataM

目次
Product Code: DMVH5839

Market Overview

Veterinary Infusion Pumps Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

The veterinary infusion pump is a device used to deliver nutrient solutions to seriously ill pets over a lengthy period and is dosed fashioned. Veterinarian infusion pumps have been essential in monitoring and analyzing fluids for various clinical problems in animals. It administers a controlled supply of nutrition, drugs, and fluids to the patient's body in precise amounts at regular intervals. These pumps' bolus dosage, preprogramming, and standby mode capabilities can completely change how blood medicines are administered.

Market Dynamics

Innovations in Veterinary Infusion Pumps are expected to drive market growth.

Advancements in implanted drug delivery systems are necessary for novel pharmacological substances, such as particular biologics, gene therapy, and other tiny molecules that cannot be delivered orally, topically, or intravenously. This invasive dosing strategy aims to directly overcome physiological barriers posed by the animal body, release the appropriate medication dosage at the treatment site, and maintain the medication's bioavailability for the necessary period following delivery to ensure medication efficacy. Modern MEMS-enabled implanted medication infusion pumps with distinctive performance and feature sets have been made possible by microtechnological advancements. Acute fast radiolabeling, short-term administration of nanomedicine for cancer treatment, and chronic ocular medication dosage are a few examples of in vivo demonstration of micropumps for laboratory animal research and preclinical studies. Moreover, Next-generation implantable pumps with excellent performance in a small form factor for clinical applications may be made possible through research into MEMS actuators, valves, and other microstructures. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint

The high cost of veterinary infusion pumps, stringent regulations for the approvals of the devices, lack of awareness of animal health among the proprietors and errors of fluid infusion pumps using different administration sets are some of the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The veterinary infusion pumps market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. For therapeutic or diagnostic purposes, infusion pumps are machines that accurately provide liquids via intravenous (IV) or epidural methods. Compared to gravity administration sets, they offer higher pressures and greater accuracy. Infusion pumps provide a significant risk to pets, so extra caution should be used while administering IV solutions or medications. The patient may suffer harm if the infusion rate or volume are set incorrectly. Every infusion device should be utilized while the pets are being closely watched.

In contrast, an economic crisis will affect agriculture and veterinary services, and a greater emphasis on the public health effects of coronavirus infections in animals on farms and pets. Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Large-Volume Infusion Pumps segment is expected to hold the largest market share in veterinary infusion pumps market

The large-volume infusion pumps segment is expected to dominate in 2021. The segment benefits as the infusion pumps can be manually or mechanically operated, offering great pain relief, fewer side effects than oral pharmaceutical treatment, and accessibility for daily tasks. Also, various infusion pumps are categorized into several categories based on their size, accuracy, technology, flow rate, battery life, and kind of infusions (continuous, intermittent). Therefore, it has led to the increased usage of large volume infusion pumps for administering parenteral nourishment, delivering fluid for blood transfusions, and in emergencies, with technological advancements in large volume infusion pumps. For instance, the IVVet Veterinary Infusion Pump from Eitan Medical combines the proprietary Flow Control Technology, state-of-the-art hardware design, user-friendly touch-screen, software-controlled pumping mechanism, and low total cost of ownership. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global veterinary infusion pumps market

In 2021, North America accounted for the highest revenue share. The significant growth rate is owing to the increase in animal adaptation rates and healthcare expenditure coupled with rising animal diseases requiring surgeries. The huge number of veterinary practices and product launches by the market players are some factors the market is expected to boost in the forecast period. For instance, according to the American Society for the Prevention of Cruelty to Animals, every year, almost 4.1 million pets are adopted from animal shelters. On average, 2.1 million cats and 2 million dogs are adopted yearly. In contrast to dogs, which are more frequently bought from breeders than adopted, cats are adopted more frequently than they are bought from breeders. Moreover, according to the Veterinary Medical Association 2020, as of December 2020, there were around 75,349 veterinarian private offices in the United States.

Additionally, to establish a national sales presence in the veterinary healthcare equipment industry, DVMPro Inc., a top supplier of veterinary diagnostic equipment for veterinary health professionals, partnered with MTMC Animal Health. The relationship between MTMC and DVMPro will cover the entire product line, which comprises Veterinary Monitoring, Ventilators & Anesthesia, Ultrasound, ECG, Infusion Pumps, Pulse Oximetry, and Blood Analysis. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the veterinary infusion pumps market are B. Braun Melsungen AG, Burtons Medical Equipment Ltd, Digicare Biomedical Technology Inc., DRE Veterinary, Grady Medical System Inc., Heska Corporation, Jorgen Kruuse, Jorgensen Laboratories, Eitan Medical, iVet Medical.

B. Braun Melsungen AG:

Overview:

B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, pain therapy products, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, ostomy, disinfection, and wound care products. The company operates its business through five divisions: hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry.

Product Portfolio:

Infusomat Space pump: The Infusomat Space pump is a volumetric infusion pump configured as an individual pump, a small therapy unit, or an advanced infusion system. The pump's compact, lightweight, and user-friendly designs unify all clinical areas into a single system while offering a user-friendly solution to complex therapies.

The global veterinary infusion pumps market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in Veterinary Infusion Pumps are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of veterinary infusion pumps is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Large-Volume Infusion Pumps*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Syringe Infusion Pumps

8. By Mobility

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 8.1.2. Market Attractiveness Index, By Mobility Segment
  • 8.2. Stationary*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Portable

9. By Channel Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 9.1.2. Market Attractiveness Index, By Channel Type Segment
  • 9.2. Single Channel*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Multi-Channel

10. By Infusion Mode

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 10.1.2. Market Attractiveness Index, By Infusion Mode Segment
  • 10.2. Rate Mode*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Time Mode
  • 10.4. Dose Mode
  • 10.5. Others

11. By End user

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.1.2. Market Attractiveness Index, By End user Segment
  • 11.2. Veterinary Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Veterinary Clinics
  • 11.4. Laboratories
  • 11.5. Homecare
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Product Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. B. Braun Melsungen AG*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Burtons Medical Equipment Ltd
  • 14.3. Digicare Biomedical Technology Inc
  • 14.4. DRE Veterinary
  • 14.5. Grady Medical System Inc.
  • 14.6. Heska Corporation
  • 14.7. Jorgen Kruuse
  • 14.8. Jorgensen Laboratories
  • 14.9. Eitan Medical
  • 14.10. iVet Medical

LIST NOT EXHAUSTIVE

15. Global Veterinary Infusion Pumps Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Applications
  • 15.3. Contact Us